• Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
Stock

Fentanyl use in US workplaces rises, study finds: report

by September 2, 2025
by September 2, 2025

More American workers are testing positive for fentanyl in randomised workplace drug screenings, a report by The Wall Street Journal said, which brings to the fore the persistent challenges the opioid epidemic poses for employers.

The rate of positive urine tests for fentanyl reached 1.13% in 2024, up from 0.91% in 2023 and more than double the rate seen in 2020, according to new data from Quest Diagnostics cited by WSJ.

The analysis reviewed more than eight million drug tests, making it one of the most comprehensive workplace drug-use studies in the country.

“We’re seeing trends that are outside of the norm that we see for other drugs historically,” said Suhash Harwani, senior director of science for workforce-health solutions at Quest Diagnostics.

The findings indicate that random tests reveal opioid use more accurately than pre-employment screenings, where candidates have time to prepare.

Fentanyl-positive results were more than seven times higher in random tests than in initial hiring screenings.

Overall drug positivity shows a decline

While fentanyl use is rising, Quest found that overall workplace drug positivity fell slightly in 2024, to 4.4% from 4.6% in 2023.

That decline follows three consecutive years of increases.

The continued prevalence of fentanyl use comes as the US grapples with an opioid crisis that has claimed hundreds of thousands of lives.

Deaths involving synthetic opioids fell slightly last year, down 2% to about 74,700, according to preliminary data from the Centres for Disease Control and Prevention.

Still, fentanyl accounted for roughly seven in 10 US overdose deaths.

Source: Statista

Fentanyl use results versus marijuana use results

Employers in industries such as construction, mining and transportation have been particularly vulnerable to substance misuse in the workforce.

Unintentional overdoses from nonmedical drug and alcohol use in the workplace rose for the 10th straight year in 2022, according to the Bureau of Labor Statistics.

The new findings suggest some workers may begin using fentanyl after passing pre-employment screenings, raising risks of on-the-job accidents, absenteeism, and overdoses.

In contrast, marijuana use trends lower in random tests compared to hiring screenings, with a 42% lower positivity rate in surprise testing over the past five years.

Why fentanyl slips through screenings

Experts note that fentanyl’s short lifespan in the body allows it to evade standard pre-employment detection more easily than other drugs.

“Fentanyl is shorter-lived than cannabis; it doesn’t stay in the bloodstream or remain detectable nearly as long,” said Alexandria Macmadu, assistant professor of epidemiology at Brown University.

“The drug can disappear from the system within hours versus up to three days for other substances.”

This means job candidates can abstain for a short period before interviews or tests and still pass screenings.

In some cases, candidates have reportedly attempted to substitute specimens to avoid detection.

Employers respond with expanded testing

The growing prevalence of fentanyl use has led more corporate clients to request that Quest Diagnostics include the drug in their testing panels.

“We’re starting to see a bit more of a shift into reasonable suspicion, random-type testing and post-incident testing,” said Janet LaQuintano, vice president of growth and strategic initiatives at staffing agency ManpowerGroup.

Human-resource professionals also report a shift away from narrow testing strategies.

“Companies are increasingly requesting a full suite of tests for all drugs rather than just marijuana,” said Julie Schweber, knowledge adviser at HR trade group SHRM.

As fentanyl continues to pose unique risks in the workplace, experts warn that employers may need to adopt even stricter monitoring and support programs to address the health and safety challenges stemming from the nation’s opioid epidemic.

The post Fentanyl use in US workplaces rises, study finds: report appeared first on Invezz

0 comment
0
FacebookTwitterPinterestEmail

previous post
Bernie Sanders calls for RFK Jr. to resign as HHS secretary over vaccine policies: ‘Rally the American people’
next post
British pubs in peril: industry calls for govt intervention to avert crisis

Related Posts

OpenAI valuation hits $500 billion as employees sell...

October 2, 2025

Here’s why JPMorgan, Morningstar are bullish on Alibaba...

October 2, 2025

Europe markets open: Stoxx 600 jumps 0.6%, led...

October 2, 2025

Will the Tesco share price hit 500p as...

October 2, 2025

Tesco lifts profit forecast as summer, price cuts,...

October 2, 2025

Chinese carmakers expand hybrid sales in Europe as...

October 2, 2025

Hackers exploit Oracle systems, executives hit with ransom...

October 2, 2025

US digest: TrumpRx launch, job data, and government...

October 1, 2025

Asian markets: Nikkei sinks 1.16%, Sensex muted ahead...

October 1, 2025

Morning brief: Asian factory data splits on US...

October 1, 2025

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent Posts

  • Wiliot and Walmart Partner to Transform Retail with Ambient IoT and AI

    October 2, 2025
  • Manual trades embracing IoT for safer workplaces

    October 2, 2025
  • Soracom and Skylo Roll Out Integrated Satellite IoT

    October 2, 2025
  • Mission Creep: The Fed’s Foray Into State and Local Debt

    October 2, 2025
  • I Was a Victim of Cancel Culture. Don’t Perpetuate It.

    October 2, 2025
  • OpenAI valuation hits $500 billion as employees sell $6.6 billion in shares

    October 2, 2025

Editors’ Picks

  • 1

    Meta executives eligible for 200% salary bonus under new pay structure

    February 21, 2025
  • 2

    Walmart earnings preview: What to expect before Thursday’s opening bell

    February 20, 2025
  • 3

    New FBI leader Kash Patel tapped to run ATF as acting director

    February 23, 2025
  • 4

    Cramer reveals a sub-sector of technology that can withstand Trump tariffs

    March 1, 2025
  • 5

    Anthropic’s newly released Claude 3.7 Sonnet can ‘think’ as long as the user wants before giving an answer

    February 25, 2025
  • 6

    Nvidia’s investment in SoundHound wasn’t all that significant after all

    March 1, 2025
  • 7

    Pop Mart reports 188% profit surge, plans aggressive global expansion

    March 26, 2025

Categories

  • Economy (2,758)
  • Editor's Pick (279)
  • Investing (185)
  • Stock (1,879)
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Read alsox

Top 4 quantum computing stocks to buy...

June 25, 2025

London braces for scorching heatwave, hottest start...

June 28, 2025

Joby Aviation stock soars 20% after Dubai...

July 1, 2025